William C Olson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William C Olson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William C Olson. William C Olson is Senior VP, Research and Develo in PROGENICS PHARMACEUTICALS INC ($PGNX) and SR. VP, Research & Development in PROGENICS PHARMACEUTICALS INC ($PGNX) and VP, Research & Development in PROGENICS PHARMACEUTICALS INC ($PGNX) and VP, Research and Development in PROGENICS PHARMACEUTICALS INC ($PGNX).
Latest Insider Trading Transactions of William C Olson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2013 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Option Exercise | A | 5.03 | 60,000 | 301,800 | 60,000 | |
| Jun 22 2012 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Sell | D | 8.69 | 1,230 | 10,685 | 45,544 | 46.8 K to 45.5 K (-2.63 %) |
| Mar 05 2012 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Option Exercise | A | 9.81 | 50,000 | 490,500 | 50,000 | |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Option Exercise | M | 4.62 | 2,605 | 12,046 | 0 | |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Payment of Exercise | F | 5.44 | 2,356 | 12,817 | 46,774 | 49.1 K to 46.8 K (-4.80 %) |
| Oct 04 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Buy | M | 4.62 | 2,605 | 12,046 | 49,130 | 46.5 K to 49.1 K (+5.60 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Option Exercise | A | 7.40 | 70,000 | 518,000 | 70,000 | |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Option Exercise | M | 5.46 | 6,335 | 34,589 | 0 | |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Payment of Exercise | F | 7.40 | 5,276 | 39,042 | 46,333 | 51.6 K to 46.3 K (-10.22 %) |
| Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Buy | M | 5.46 | 6,335 | 34,589 | 51,609 | 45.3 K to 51.6 K (+13.99 %) |
| Jun 22 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Sell | S | 7.11 | 106 | 754 | 44,974 | 45.1 K to 45 K (-0.24 %) |
| Jun 22 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | Senior VP, Research ... | Sell | S | 7.09 | 2,766 | 19,605 | 45,080 | 47.8 K to 45.1 K (-5.78 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | A | 6.18 | 2,057 | 12,712 | 2,057 | |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | M | 5.05 | 2,373 | 11,984 | 0 | |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Payment of Exercise | F | 6.29 | 2,075 | 13,052 | 47,846 | 49.9 K to 47.8 K (-4.16 %) |
| Apr 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Buy | M | 5.05 | 2,373 | 11,984 | 49,921 | 47.5 K to 49.9 K (+4.99 %) |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | D | 5.46 | 5,308 | 28,982 | 5,308 | |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | M | 4.83 | 2,582 | 12,466 | 0 | |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Payment of Exercise | F | 5.68 | 2,351 | 13,354 | 47,304 | 49.7 K to 47.3 K (-4.73 %) |
| Jan 05 2011 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Buy | M | 4.83 | 2,582 | 12,466 | 49,655 | 47.1 K to 49.7 K (+5.49 %) |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | A | 5.05 | 2,373 | 11,984 | 2,373 | |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | M | 4.32 | 6,915 | 29,859 | 0 | |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Payment of Exercise | F | 5.08 | 6,254 | 31,770 | 46,871 | 53.1 K to 46.9 K (-11.77 %) |
| Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Buy | M | 4.32 | 6,915 | 29,859 | 53,125 | 46.2 K to 53.1 K (+14.96 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | A | 5.35 | 30,000 | 160,500 | 30,000 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | A | 5.48 | 2,187 | 11,985 | 2,187 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Option Exercise | M | 4.44 | 2,541 | 11,282 | 0 | |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Grant | A | 0.00 | 10,000 | 0 | 45,992 | 36 K to 46 K (+27.78 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Payment of Exercise | F | 5.35 | 2,282 | 12,209 | 35,992 | 38.3 K to 36 K (-5.96 %) |
| Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | SR. VP, Research & ... | Buy | M | 4.44 | 2,541 | 11,282 | 38,274 | 35.7 K to 38.3 K (+7.11 %) |
| Jun 24 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 5.81 | 2,364 | 13,723 | 35,494 | 37.9 K to 35.5 K (-6.24 %) |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 5.33 | 2,117 | 11,284 | 2,117 | |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.56 | 2,490 | 11,344 | 0 | |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 5.36 | 2,266 | 12,146 | 37,858 | 40.1 K to 37.9 K (-5.65 %) |
| Apr 05 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.56 | 2,490 | 11,344 | 40,124 | 37.6 K to 40.1 K (+6.62 %) |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 4.44 | 6,370 | 28,283 | 6,370 | |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 3.78 | 2,989 | 11,307 | 0 | |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 4.45 | 2,720 | 12,104 | 37,427 | 40.1 K to 37.4 K (-6.78 %) |
| Jan 06 2010 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 3.78 | 2,989 | 11,307 | 40,147 | 37.2 K to 40.1 K (+8.04 %) |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 5.24 | 2,153 | 11,282 | 2,153 | |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.26 | 2,533 | 10,788 | 0 | |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 5.01 | 2,305 | 11,548 | 36,910 | 39.2 K to 36.9 K (-5.88 %) |
| Oct 05 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.26 | 2,533 | 10,788 | 39,215 | 36.7 K to 39.2 K (+6.91 %) |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 5.33 | 50,000 | 266,500 | 50,000 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 5.33 | 6,461 | 34,437 | 0 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 5.15 | 2,191 | 11,284 | 2,191 | |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 5.33 | 5,880 | 31,340 | 36,472 | 42.4 K to 36.5 K (-13.88 %) |
| Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 5.33 | 6,461 | 34,437 | 42,352 | 35.9 K to 42.4 K (+18.00 %) |
| Jun 24 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 4.73 | 2,500 | 11,815 | 35,677 | 38.2 K to 35.7 K (-6.55 %) |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 6.59 | 1,712 | 11,282 | 1,712 | |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 5.65 | 2,014 | 11,379 | 0 | |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 5.65 | 2,014 | 11,379 | 38,177 | 36.2 K to 38.2 K (+5.57 %) |
| Apr 03 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 6.65 | 1,832 | 12,183 | 36,163 | 38 K to 36.2 K (-4.82 %) |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 10.31 | 2,307 | 23,785 | 2,307 | |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 9.13 | 1,287 | 11,750 | 0 | |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 10.74 | 1,171 | 12,577 | 37,827 | 39 K to 37.8 K (-3.00 %) |
| Jan 06 2009 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 9.13 | 1,287 | 11,750 | 38,998 | 37.7 K to 39 K (+3.41 %) |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 13.31 | 848 | 11,287 | 848 | |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 6.53 | 1,484 | 9,691 | 0 | |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 13.93 | 1,011 | 14,083 | 37,604 | 38.6 K to 37.6 K (-2.62 %) |
| Oct 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 6.53 | 1,484 | 9,691 | 38,615 | 37.1 K to 38.6 K (+4.00 %) |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 16.05 | 20,000 | 321,000 | 20,000 | |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 15.87 | 610 | 9,681 | 610 | |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 13.64 | 2,296 | 31,317 | 0 | |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Grant | A | 0.00 | 6,667 | 0 | 36,622 | 30 K to 36.6 K (+22.26 %) |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 16.05 | 2,089 | 33,528 | 29,955 | 32 K to 30 K (-6.52 %) |
| Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 13.64 | 2,296 | 31,317 | 32,044 | 29.7 K to 32 K (+7.72 %) |
| Jun 24 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | D | 17.01 | 3,500 | 59,546 | 29,678 | 33.2 K to 29.7 K (-10.55 %) |
| Apr 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 6.53 | 1,484 | 9,691 | 1,484 | |
| Apr 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 6.52 | 1,576 | 10,276 | 0 | |
| Apr 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 7.67 | 1,435 | 11,006 | 33,178 | 34.6 K to 33.2 K (-4.15 %) |
| Apr 03 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 6.52 | 1,576 | 10,276 | 34,613 | 33 K to 34.6 K (+4.77 %) |
| Jan 04 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 18.07 | 1,951 | 35,255 | 1,951 | |
| Jan 04 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 15.33 | 570 | 8,738 | 0 | |
| Jan 04 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 18.03 | 519 | 9,358 | 32,868 | 33.4 K to 32.9 K (-1.55 %) |
| Jan 04 2008 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 15.33 | 570 | 8,738 | 33,387 | 32.8 K to 33.4 K (+1.74 %) |
| Dec 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 4,000 | 16,000 | 0 | |
| Dec 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 19.03 | 4,000 | 76,112 | 32,756 | 36.8 K to 32.8 K (-10.88 %) |
| Dec 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 4,000 | 16,000 | 28,756 | 24.8 K to 28.8 K (+16.16 %) |
| Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 22.11 | 396 | 8,756 | 396 | |
| Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 19.03 | 466 | 8,868 | 0 | |
| Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 22.39 | 424 | 9,493 | 32,756 | 33.2 K to 32.8 K (-1.28 %) |
| Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 19.03 | 466 | 8,868 | 33,180 | 32.7 K to 33.2 K (+1.42 %) |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 22.01 | 7,000 | 154,070 | 7,000 | |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 21.57 | 406 | 8,757 | 406 | |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 18.71 | 1,546 | 28,926 | 0 | |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 22.01 | 1,407 | 30,968 | 32,664 | 34.1 K to 32.7 K (-4.13 %) |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 18.71 | 1,546 | 28,926 | 34,071 | 32.5 K to 34.1 K (+4.75 %) |
| Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Grant | A | 0.00 | 9,333 | 0 | 32,525 | 23.2 K to 32.5 K (+40.24 %) |
| Jun 21 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | D | 22.83 | 1,000 | 22,829 | 23,141 | 24.1 K to 23.1 K (-4.14 %) |
| Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 20.13 | 414 | 8,334 | 414 | |
| Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 20.13 | 394 | 7,931 | 0 | |
| Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 24.10 | 355 | 8,556 | 24,141 | 24.5 K to 24.1 K (-1.45 %) |
| Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 20.13 | 394 | 7,931 | 24,496 | 24.1 K to 24.5 K (+1.63 %) |
| Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 21.88 | 362 | 7,921 | 0 | |
| Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 25.74 | 335 | 8,623 | 335 | |
| Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 26.66 | 323 | 8,611 | 24,051 | 24.4 K to 24.1 K (-1.33 %) |
| Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 21.88 | 362 | 7,921 | 24,374 | 24 K to 24.4 K (+1.51 %) |
| Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 23.46 | 338 | 7,929 | 338 | |
| Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 19.58 | 397 | 7,773 | 0 | |
| Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 23.03 | 362 | 8,337 | 23,961 | 24.3 K to 24 K (-1.49 %) |
| Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 19.58 | 397 | 7,773 | 24,323 | 23.9 K to 24.3 K (+1.66 %) |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 24.26 | 17,500 | 424,550 | 17,500 | |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 24.26 | 329 | 7,982 | 329 | |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 20.45 | 1,365 | 27,916 | 0 | |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Grant | A | 0.00 | 6,500 | 0 | 23,879 | 17.4 K to 23.9 K (+37.40 %) |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 24.26 | 1,237 | 30,010 | 17,379 | 18.6 K to 17.4 K (-6.64 %) |
| Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 20.45 | 1,365 | 27,916 | 18,616 | 17.3 K to 18.6 K (+7.91 %) |
| Jun 22 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 21.62 | 1,000 | 21,620 | 17,203 | 18.2 K to 17.2 K (-5.49 %) |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 3,893 | 15,572 | 2,000 | |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 10,107 | 40,428 | 5,893 | |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 24.00 | 3,893 | 93,432 | 18,203 | 22.1 K to 18.2 K (-17.62 %) |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 3,893 | 15,572 | 22,096 | 18.2 K to 22.1 K (+21.39 %) |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 24.00 | 10,107 | 242,568 | 18,203 | 28.3 K to 18.2 K (-35.70 %) |
| May 08 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 10,107 | 40,428 | 28,310 | 18.2 K to 28.3 K (+55.52 %) |
| Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 26.49 | 299 | 7,921 | 299 | |
| Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 21.77 | 305 | 6,640 | 0 | |
| Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 25.61 | 277 | 7,094 | 18,203 | 18.5 K to 18.2 K (-1.50 %) |
| Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 21.77 | 305 | 6,640 | 18,480 | 18.2 K to 18.5 K (+1.68 %) |
| Mar 21 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 2,000 | 8,000 | 16,000 | |
| Mar 21 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 27.46 | 2,000 | 54,920 | 18,135 | 20.1 K to 18.1 K (-9.93 %) |
| Mar 21 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 2,000 | 8,000 | 20,135 | 18.1 K to 20.1 K (+11.03 %) |
| Mar 01 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 2,000 | 8,000 | 2,000 | |
| Mar 01 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 24.45 | 2,000 | 48,906 | 18,135 | 20.1 K to 18.1 K (-9.93 %) |
| Mar 01 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 2,000 | 8,000 | 20,135 | 18.1 K to 20.1 K (+11.03 %) |
| Feb 23 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 4.00 | 2,000 | 8,000 | 18,000 | |
| Feb 23 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Sell | S | 28.01 | 2,000 | 56,020 | 18,135 | 20.1 K to 18.1 K (-9.93 %) |
| Feb 23 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 4.00 | 2,000 | 8,000 | 20,135 | 18.1 K to 20.1 K (+11.03 %) |
| Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 25.01 | 775 | 19,383 | 775 | |
| Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 20.86 | 330 | 6,884 | 0 | |
| Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 25.84 | 291 | 7,519 | 18,135 | 18.4 K to 18.1 K (-1.58 %) |
| Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 20.86 | 330 | 6,884 | 18,426 | 18.1 K to 18.4 K (+1.82 %) |
| Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 23.71 | 290 | 6,876 | 290 | |
| Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | M | 16.81 | 409 | 6,875 | 0 | |
| Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Payment of Exercise | F | 24.67 | 331 | 8,166 | 18,038 | 18.4 K to 18 K (-1.80 %) |
| Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Buy | M | 16.81 | 409 | 6,875 | 18,369 | 18 K to 18.4 K (+2.28 %) |
| Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 21.39 | 12,500 | 267,375 | 12,500 | |
| Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Option Exercise | A | 20.86 | 329 | 6,863 | 329 | |
| Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Grant | A | 0.00 | 4,500 | 0 | 17,770 | 13.3 K to 17.8 K (+33.91 %) |
| Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research & Deve ... | Grant | A | 17.16 | 159 | 2,728 | 13,270 | 13.1 K to 13.3 K (+1.21 %) |
| Jun 22 2005 | PGNX | PROGENICS PHARMACE ... | Olson William C | VP, Research and De ... | Sell | S | 20.00 | 650 | 13,000 | 13,111 | 13.8 K to 13.1 K (-4.72 %) |
Page: 1